搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
10 小时
Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies
Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...
The Globe and Mail
19 小时
BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
"The STRIDES trial is a critical step in our mission to improve outcomes for patients with obesity. We're developing an oral therapy that has the potential to enhance the weight loss benefits of ...
19 小时
BioAge Labs to Present Preclinical Data for APJ Agonist Azelaprag at ObesityWeek 2024
Detailed price information for Bioage Labs Inc (BIOA-Q) from The Globe and Mail including charting and trades.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
US ambassador to UN
Ex-Rep. Grimm paralyzed
Taking charge of US borders
Schweikert wins reelection
Cruise ship rescues 4 people
CA forced labor ban rejected
AZ rejects 'curing' extension
24 more monkeys found
China builds nuclear reactor?
Shooting suspect arrested
TN murder suspect arrested
Ella Jenkins dies at 100
US military targets Houthis
COP29 summit begins
Reds honor Pete Rose
FTX sues Binance
Quincy Jones laid to rest
Bitcoin hits $82,000
Wins 3rd NASCAR Cup title
Israel strikes Gaza, Lebanon
Haiti replaces prime minister
Tops box office with $16.2M
Delaney wins US House seat
Ranger dies in wildfire
UN nuclear head to visit Iran
UKR drones strike Moscow
Judith Jamison dies
FTX sues Scaramucci
反馈